Reape Kathleen 4
4 · Taysha Gene Therapies, Inc. · Filed Jun 22, 2022
Insider Transaction Report
Form 4
Reape Kathleen
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-17+15,500→ 15,500 totalExercise: $2.81Exp: 2032-06-17→ Common Stock (15,500 underlying)
Footnotes (1)
- [F1]The shares vest on the earlier of June 17, 2023 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director though the applicable vesting date.